期刊文献+

The S267F variant of sodium taurocholate co-transporting polypeptide is strongly associated with resistance to chronic hepatitis B and high level of serum total bile acids 被引量:1

原文传递
导出
摘要 Background and aims:The sodium taurocholate co-transporting polypeptide(NTCP)is a functional receptor for the hepatitis B virus(HBV),and it is critical for bile acid homeostasis.Previous studies of the association between the S267F variant and chronic hepatitis B(CHB)have generated conflicting results.This study analyzed the correlation between the NTCP S267F variant and CHB susceptibility by using a large sample of participants classified by gender and age,and this study also analyzed the relationship between this variant and the level of serum total bile acids.Methods:In total,543 patients with CHB and 429 control subjects underwent S267F variant genotyping using SNaPshot technology.Logistic regression was utilized to evaluate any association of the NTCP S267F variant with CHB susceptibility.Results:The S267F variant was inversely correlated with the risk of chronic HBV infection in both the dominant model(GG genotype vs.AG genotype:odds ratio(OR)=0.46,95%confidence interval(CI)0.30 -0.71,P<0.001)and the allele model(G allele vs.A allele:OR=0.50,95%CI 0.33-0.76,P=0.001),and this correlation was not affected by gender and age stratification.The carriers of the heterozygous NTCP variant exhibited higher total bile acids levels than the carriers of wild-type NTCP,regardless of whether they were control subjects or patients with CHB.Heterozygous carriers exhibited reduced hepatitis B e antigen(HBeAg)-positivity rates and had lower ALT,AST,and lg DNA concentrations compared with wild-type carriers in patients with CHB.Conclusions:The S267F variant of NTCP is a protective factor that reduces the risk of chronic HBV infection and exhibits a higher total bile acids level.Patients with CHB who carry this variant may have a better prognosis than those carrying wild-type NTCP.
出处 《Liver Research》 CSCD 2022年第3期186-190,共5页 肝脏研究(英文)
基金 This study was funded by the Natural Science Foundation of Fujian Province(No.2021J011447) Ningde Science and Technology Plan Project(No.20170032).
  • 相关文献

参考文献2

二级参考文献44

  • 1[43]Griffiths PD. Interactions between viral and human genes. Rev Med Virol 2002; 12:197-199
  • 2[44]Dean M, Carrington M, O′Brien SJ. Balanced polymorphism selected by genetic versus infectious human disease. Annu Rev Genomics Hum Genet 2002; 3:263-292
  • 3[1]Gu CH, Luo KX. Hepatitis B: Basic biology and clinical science. Second edition. Beijing, People′s Medical Publishing House 2001:1-6
  • 4[2]Iino S. Natural history of hepatitis B and C virus infections. Oncology 2002; 62(Suppl 1): 18-23
  • 5[3]Luo KX. Hepatitis B: Basic biology and clinical science. Second edition. Beijing, People′s Medical Publishing House 2001:56-70
  • 6[4]Ferrari C. Hepatitis B virus immunopathogenesis. Annu Rev Immunol 1995; 13:29-60
  • 7[5]Guidotti LG, Chisari FV. Noncytolytic control of viral infections by the innate and adaptive immune response. Annu Rev Immunol 2001; 19:65-91
  • 8[6]Abel L, Dessein AJ. The impact of host genetics on susceptibility to human infectious diseases. Curr Opin Immunol 1997; 9:509-516
  • 9[7]McNicholl J. Host genes and infectious diseases. Emerg Infect Dis 1998; 4:423-426
  • 10[8]McNicholl JM, Cuenco KT. Host genes and infectious diseases.HIV, other pathogens, and a public health perspective. Am J Prev Med 1999; 16:141-154

共引文献112

同被引文献5

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部